| Literature DB >> 21515905 |
Magdalena Ietswaart1, Marie Johnston, H Chris Dijkerman, Sara Joice, Clare L Scott, Ronald S MacWalter, Steven J C Hamilton.
Abstract
This randomized controlled trial evaluated the therapeutic benefit of mental practice with motor imagery in stroke patients with persistent upper limb motor weakness. There is evidence to suggest that mental rehearsal of movement can produce effects normally attributed to practising the actual movements. Imagining hand movements could stimulate restitution and redistribution of brain activity, which accompanies recovery of hand function, thus resulting in a reduced motor deficit. Current efficacy evidence for mental practice with motor imagery in stroke is insufficient due to methodological limitations. This randomized controlled sequential cohort study included 121 stroke patients with a residual upper limb weakness within 6 months following stroke (on average <3 months post-stroke). Randomization was performed using an automated statistical minimizing procedure. The primary outcome measure was a blinded rating on the Action Research Arm test. The study analysed the outcome of 39 patients involved in 4 weeks of mental rehearsal of upper limb movements during 45-min supervised sessions three times a week and structured independent sessions twice a week, compared to 31 patients who performed equally intensive non-motor mental rehearsal, and 32 patients receiving normal care without additional training. No differences between the treatment groups were found at baseline or outcome on the Action Research Arm Test (ANCOVA statistical P=0.77, and effect size partial η2=0.005) or any of the secondary outcome measures. Results suggest that mental practice with motor imagery does not enhance motor recovery in patients early post-stroke. In light of the evidence, it remains to be seen whether mental practice with motor imagery is a valid rehabilitation technique in its own right.Entities:
Mesh:
Year: 2011 PMID: 21515905 PMCID: PMC3097892 DOI: 10.1093/brain/awr077
Source DB: PubMed Journal: Brain ISSN: 0006-8950 Impact factor: 13.501
Demographic and clinical characteristics at baseline for the experimental ‘Motor Imagery Training’ treatment group, the ‘Attention-Placebo Control’ group and the ‘Normal Care Control’ group
| Motor Imagery Training ( | Attention-Placebo Control ( | Normal Care Control ( | |
|---|---|---|---|
| Age in years (SD) | 69.3 (10.8) | 68.6 (16.3) | 64.4 (15.9) |
| Gender (male/female) | 23/18 | 22/17 | 25/16 |
| Education in years (SD) | 10.6 (1.7) | 10.6 (1.4) | 10.3 (1.7) |
| Hospitalization (in-patient/out-patient) | 31/10 | 32/7 | 31/10 |
| Lesion side (left/right/subcortical or bilateral/no data) | 13/16/10/2 | 12/12/10/5 | 18/12/9/2 |
| Side of weakness (left/right) | 24/17 | 23/16 | 22/19 |
| Time post-stroke in days (SD) | 82.0 (55.0) | 90.8 (63.4) | 80.5 (62.7) |
| Spontaneous motor imagery use (yes/no/no data) | 14/18/9 | 14/13/12 | 14/16/11 |
| Receiving other rehab therapy (yes/no) | 33/8 | 35/4 | 34/7 |
| MSQ score out of 10 (SD) | 8.9 (1.0) | 8.7 (1.2) | 9.1 (0.9) |
| HADS score out of 42 (SD) | 13.4 (7.8) | 13.7 (7.7) | 13.2 (8.0) |
| Location baseline assessment (hospital/home/university) | 27/9/5 | 29/7/3 | 28/9/4 |
| Baseline and outcome at same location (yes/no) | 38/3 | 34/5 | 41/0 |
HADS = Hospital Anxiety and Depression Scale; MSQ = Mental Status Questionnaire.
Percentage power to detect differences between the three groups at error level (alpha) 0.05 for ANCOVA when there is a small, medium or large effect size according to Cohen (1992) for a range of sample sizes, including the recruited sample size (n = 121) and the number of completions (n = 102)
| Small, | 17% | 15% | 13% | 11% |
| Medium, | 75% | 68% | 60% | 49% |
| Large, | 99% | 98% | 95% | 89% |
Figure 1Flow diagram summarizing the passage of participants through the stages of the trial.
Mean performance and ANCOVA analysis group differences on primary and secondary outcome measures, for the experimental ‘Motor Imagery Training’ treatment group, the ‘Attention-Placebo Control’ and the ‘Normal Care Control’ group
| Group | Baseline assessment | Outcome assessment | Between group difference | ||
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | ||||
| Upper limb impairment (ARAT) | |||||
| Motor Imagery Training | 39 | 25.64 (18.10) | 31.51 (20.68) | 0.77 | 0.005 |
| Attention-Placebo Control | 31 | 26.23 (17.92) | 32.87 (20.76) | ||
| Normal Care Control | 32 | 23.06 (17.66) | 30.38 (20.53) | ||
| Grip strength (force affected/unaffected hand, %) | |||||
| Motor Imagery Training | 39 | 32.64 (34.17) | 38.15 (36.07) | 0.60 | 0.000 |
| Attention-Placebo Control | 31 | 27.90 (29.95) | 34.55 (34.84) | ||
| Normal Care Control | 32 | 25.12 (27.97) | 34.32 (33.80) | ||
| Hand function (manual dexterity performance speed in s) | |||||
| Motor Imagery Training | 39 | 121.46 (53.32) | 104.44 (55.93) | 0.98 | 0.000 |
| Attention-Placebo Control | 31 | 109.30 (54.17) | 95.71 (57.59) | ||
| Normal Care Control | 32 | 124.02 (52.29) | 107.28 (56.20) | ||
| Activities of daily living level (Barthel Index) | |||||
| Motor Imagery Training | 39 | 13.08 (4.81) | 16.23 (4.13) | 0.38 | 0.019 |
| Attention-Placebo Control | 31 | 14.87 (4.33) | 16.84 (3.75) | ||
| Normal Care Control | 32 | 12.28 (5.41) | 14.87 (4.79) | ||
| Functional limitations profile | |||||
| Motor Imagery Training | 38 | 58.40 (15.02) | 50.28 (18.78) | 0.98 | 0.000 |
| Attention-Placebo Control | 31 | 64.16 (14.04) | 55.42 (15.81) | ||
| Normal Care Control | 31 | 62.50 (14.26) | 53.49 (18.68) | ||